- Total software segment revenues of $26.3 million, up 53% year-over-year - Consolidated revenue of $44.2 million, up 37% year-over-year - SaaS bookings at record levels, up 41% over 3rd quarter of prior year
SALT LAKE CITY , Nov.
- Q3 revenues of $1.56B, increase of 8% over Q3 revenues in 2013 - - Operating profit of $262M, 18% increase over Q3 2013 - - Adjusted net income for the third quarter is $180M, 8.2% less than the parallel period in Q3 2013, impacted by short term exchange rate fluctuations and higher taxes -
- ICL continues to implement its "Next Step Forward" strategy: ICL Performance Products segment signs agreement to divest several non-core businesses for $260M (after taxes); proceeds to be invested in ICL's core businesses in agriculture, food and engineered materials ICL to invest $435M in several stages until 2017 for capacity expansion and optimization of salt and potash production at ICL Iberia's Suria mine and Barcelona Port sites Efficiency plan will lead to $80M savings by year end 2014 and to $350M by the end of 2016 Company evaluating additional ways of accelerating its growth and diversification of mineral resources outside of Israel TEL AVIV, Israel ,
Incyte Corporation (Nasdaq:INCY) and Agenus Inc. (Nasdaq:AGEN) today
announced a global license, development and commercialization agreement
focused on novel immuno-therapeutics using Agenus’ proprietary Retrocyte
Display™ antibody discovery platform.
Incyte Corporation (Nasdaq: INCY) today reported 2014 third-quarter
financial results, including revenue from Jakafi ®
(ruxolitinib). The Company highlighted the strength in Jakafi sales in
the U.S. as well as the recognition of two significant milestone
payments from Novartis related to Jakavi ® (ruxolitinib),
totaling $85 million.
Incyte Corporation (Nasdaq:INCY) announced today it will present at the
following investor conferences during the month of December:
The presentations will be webcast live and can be accessed at www.incyte.com
under Investor Relations, Events and Webcasts.
Independence Realty Trust, Inc. (“IRT”) (NYSE MKT: IRT) today announced
that, on December 30, 2014, IRT acquired an apartment community located
in Austin, Texas for a purchase price of approximately $35.3 million.
Independence Realty Trust, Inc. (NYSE MKT: IRT) (“IRT”) today announced
that, on January 19, 2015, IRT’s Board of Directors declared monthly
cash dividends for the first quarter of 2015 on IRT’s shares of common
stock in the amount of $0.06 per share per month.
Independence Realty Trust, Inc. (“IRT”) (NYSE MKT:IRT) today announced
that, on December 16, 2014, IRT acquired an apartment community located
in Little Rock, Arkansas for a purchase price of $31.6 million.
Independence Realty Trust, Inc. (NYSE MKT: IRT) (the "Company") today
announced the pricing of its public offering of 6,000,000 shares of
common stock at a public offering price of $9.60 per share for total
gross proceeds of $57.6 million.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.